Levosimendan


Generic Medicine Info
Contraindications
History of torsade de pointes. Severe renal and hepatic impairment.
Special Precautions
Patient w/ severe hypotension, tachycardia or w/ mechanical obstruction affecting ventricular filling or outflow; ongoing coronary ischaemic or long QTc interval. Renal and hepatic impairment. Monitoring Parameters Closely monitor ECG, serum K concentration. Monitor haemodynamic effects for several days after the end of infusion as they may be prolonged.
Adverse Reactions
Headache, dizziness, hypotension, ventricular tachycardia, extrasystoles, AF, hypokalaemia, insomnia, GI disturbances and anaemia.
Potentially Fatal: Arrhythmias, tachycardia, AF w/ rapid ventricular response.
CIMS Class
Other Cardiovascular Drugs
ATC Classification
C01CX08 - levosimendan ; Belongs to the class of other cardiac stimulants excluding glycosides. Used in the treatment of heart failure.
Disclaimer: This information is independently developed by CIMS based on levosimendan from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in